Halozyme Therapeutics | HALO - Market Capitalization



Halozyme Therapeutics reported $9.33B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.61B 840M Jun/2025
Agios Pharmaceuticals USD 1.93B 234M Jun/2025
Alnylam Pharmaceuticals USD 42.52B 7.39B Jun/2025
Amgen USD 150.13B 17.37B Jun/2025
Baxter International USD 15.54B 2.02B Jun/2025
Cytokinetics USD 3.95B 846M Jun/2025
DBV Technologies USD 370M 113M Sep/2025
Eli Lilly USD 738.79B 2.87B Jun/2025
Halozyme Therapeutics USD 6.41B 1.47B Jun/2025
Ionis Pharmaceuticals USD 6.29B 1.49B Jun/2025
MannKind USD 1.14B 392M Jun/2025
Pfizer USD 137.53B 6.19B Jun/2025
United Therapeutics USD 12.96B 934M Jun/2025